Tema Etfs LLC Mirum Pharmaceuticals, Inc. Transaction History
Tema Etfs LLC
- $335 Billion
- Q1 2025
A detailed history of Tema Etfs LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Tema Etfs LLC holds 11,432 shares of MIRM stock, worth $508,266. This represents 0.15% of its overall portfolio holdings.
Number of Shares
11,432
Previous 41,968
72.76%
Holding current value
$508,266
Previous $1.74 Billion
70.32%
% of portfolio
0.15%
Previous 0.72%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
225Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$302 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$212 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$144 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$124 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$113 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.63B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...